APA Citation

Mascarenhas, J., Baer, M., Kessler, C., Hexner, E., Tremblay, D., Price, L., . . . Hoffman, R. (2019). Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis. Leuk Lymphoma.

Citação norma Chicago

Mascarenhas, J., et al. "Phase II Trial of Lestaurtinib, a JAK2 Inhibitor, in Patients With Myelofibrosis." Leuk Lymphoma 2019.

MLA Citation

Mascarenhas, J., et al. "Phase II Trial of Lestaurtinib, a JAK2 Inhibitor, in Patients With Myelofibrosis." Leuk Lymphoma 2019.

Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.